CAI Earnings Caris Life Sciences, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–9 of 9
| Q1 2026 | 2026-03-31 | 0.00 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | -3.22 | 2026-03-03 | 10-K |
| Q3 2025 | 2025-09-30 | -4.83 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -12.80 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -3.57 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | -10.66 | 2026-03-03 | 10-K |
| Q3 2025 | 2024-09-30 | -8.92 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -6.34 | 2025-08-12 | 10-Q |
| FY 2025 | 2023-12-31 | -13.24 | 2026-03-03 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.